| #32 |
Alessandro Strebel |
Basilea Pharmaceutica Ag |
2 |
| #32 |
Mirjana Andjelkovic |
Hoffmann-La Roche |
2 |
| #32 |
Rainer Albert |
Novartis Ag |
2 |
| #32 |
Urs Lehmann |
Ciba Specialty Chemicals |
2 |
| #32 |
Felix Bachmann |
Basilea Pharmaceutica Ag |
2 |
| #32 |
Franco E. Di Padova |
Novartis Ag |
2 |
| #32 |
David Banner |
Siena Biotech S.P.A. |
2 |
| #32 |
Kurt Puentener |
Hoffmann-La Roche |
2 |
| #32 |
Fiona Murphy Kessabi |
Syngenta Crop Protection Ag |
2 |
| #60 |
Lukas Giger |
Depuy Synthes Products |
1 |
| #60 |
Kurt Laumen |
Novartis Ag |
1 |
| #60 |
Juerg Hunziker |
Novartis Ag |
1 |
| #60 |
Dorte Renneberg |
Actelion Pharmaceuticals |
1 |
| #60 |
Laurenz Gsell |
Ciba-Geigy |
1 |
| #60 |
Walter Ferlin |
Novimmune Sa |
1 |
| #60 |
Dominik Feuerbach |
Novartis Ag |
1 |
| #60 |
Stephan Roever |
Hoffmann-La Roche |
1 |
| #60 |
Stefan Mathys |
Synthes Usa |
1 |
| #60 |
Walter Scherrer |
Novartis Ag |
1 |
| #60 |
Franz Metzger |
Chemspeed Technologies Ag |
1 |
| #60 |
Georg Szaloky |
Endress+Hauser Flowtec Ag |
1 |
| #60 |
Samuel Joseph Bichsel |
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Resear |
1 |
| #60 |
Andrej Trampuz |
Mayo Foundation |
1 |
| #60 |
Dieter Steinfatt |
— |
1 |
| #60 |
Max Peter Seiler |
Novartis Ag |
1 |
| #60 |
Bernd Eschgfaller |
Noxxon Pharma Ag |
1 |
| #60 |
Susanne Raab |
Hoffmann-La Roche |
1 |
| #60 |
Colin Edward Mills |
Syngenta Crop Protection Ag |
1 |
| #60 |
Bernard Pirard |
Novartis Ag |
1 |
| #60 |
Thomas Eichenberger |
Ciba Specialty Chemicals |
1 |
| #60 |
Terence O'Reilly |
Novartis Ag |
1 |
| #60 |
Aurelia Conte |
Hoffmann-La Roche |
1 |
| #60 |
Ulrich Zutter |
Hoffmann-La Roche |
1 |
| #60 |
Francois Pautrat |
Novartis Ag |
1 |
| #60 |
Ernst Kuesters |
Novartis Ag |
1 |
| #60 |
Joanna Hergovich Lisztwan |
Novartis Ag |
1 |
| #60 |
Hugues Matile |
Medicines For Malaria Venture |
1 |
| #60 |
Christian Rene Schnell |
Novartis Ag |
1 |
| #60 |
Erwin Marti |
Novartis Ag |
1 |
| #60 |
Rosemarie Sift Carter |
— |
1 |
| #60 |
Stefano Biondi |
Nicox S.A. |
1 |
| #60 |
Angela Wildermann |
Dsm Ip Assets B.V. |
1 |
| #60 |
Stephane Courvoisier |
Straumann Holding Ag |
1 |
| #60 |
Reto Störi |
Multi-Holding Ag |
1 |
| #60 |
Oliver Eich |
Clariant Finance (Bvi) Limited |
1 |
| #60 |
Thomas Müggler |
Universitat Zurich |
1 |
| #60 |
Andreas Boettcher |
Novartis Ag |
1 |
| #60 |
Josée Dannacher |
Basf Se |
1 |
| #60 |
Ulrike Nettekoven |
Solvias Ag |
1 |
| #60 |
Josef Stadlwieser |
Hoffmann-La Roche |
1 |